Aktieanalys

Cellavision Q1’22: Slighty more upbeat - Redeye

{newsItem.title}

Redeye Publicerad: 10 May 2022 08:37

Redeyes view on the Q1 report. With a report slightly above our estimates, we only make minor adjustments to our forecasts for the current year. We leave our Base case at SEK 340 unchanged.

Länk till analysen i sin helhet: https://www.redeye.se/research/841323/cellavision-q122-slighty-more-upbeat?utm_source=finwire&utm_medium=RSS

Nyheter om CellaVision

Läses av andra just nu

Om aktien CellaVision

Senaste nytt